Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 7.11% vs 11.91% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -120.45% vs -138.36% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 206.08% vs -110.44% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -14.75% vs 14.42% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Orchid Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 7.11% vs 11.91% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -4.63% vs -1.47% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -120.45% vs -138.36% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -160.68% vs -29.39% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 206.08% vs -110.44% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -94.04% vs -25.52% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -14.75% vs 14.42% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -16.32% vs 7.34% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






